HealthEquity, Inc. provided earnings guidance for the fiscal year ending January 31, 2025. For the fiscal year ending January 31, 2025, management expects revenues of $1.14 billion to $1.16 billion. Its outlook for net income is between $73 million and $88 million, resulting in net income of $0.83 to $0.99 per diluted share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.23 USD | +0.87% | -1.33% | +19.50% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.50% | 6.77B | |
+9.97% | 3,022B | |
+5.91% | 81.91B | |
+4.68% | 76.64B | |
-16.04% | 52.31B | |
+46.83% | 51.96B | |
-23.61% | 47.77B | |
+26.95% | 43.3B | |
+63.28% | 38.29B | |
-12.27% | 25.1B |
- Stock Market
- Equities
- HQY Stock
- News HealthEquity, Inc.
- HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025